Alecensa 150 MG capsule UU 240S
Ended Awarded Last action
- Contract number
- SPE2DR26FFBS3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $66,134
Award facts
- Contract value 100% obligated
- $66,133.70 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $66,133.70 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for 240 units of Alecensa 150 mg capsules. The award, issued on December 23, 2025, with an ultimate completion date of January 15, 2026, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. DMS Pharmaceutical Group will perform the work at its Park Ridge location and will serve as the sole contractor on this delivery order with no identified subcontractors.
This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract (IDC) with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy designed to supply the Department of Defense with a full range of pharmaceutical products and medical consumables for military healthcare facilities worldwide. The underlying IDC, awarded November 13, 2025, carries a ceiling value of $499.9 million and extends through December 31, 2036, with a 30-month base period and three 30-month option periods. As a critical supplier within the federal pharmaceutical supply chain, DMS Pharmaceutical Group has demonstrated substantial federal contracting activity and positions itself to fulfill diverse and specialized pharmaceutical requirements across the military medical system.
Quick answers
Who was awarded contract SPE2DR26FFBS3?
SPE2DR26FFBS3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on December 23, 2025.
How much is contract SPE2DR26FFBS3 worth?
The government has obligated $66,134 on SPE2DR26FFBS3.
Is contract SPE2DR26FFBS3 an order under another contract?
Yes. SPE2DR26FFBS3 is a delivery order under SPE2DR25D9239, an indefinite delivery contract.
Was contract SPE2DR26FFBS3 competed?
The extent of competition for SPE2DR26FFBS3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award